Trial record 1 of 1 for:    Immunotherapy with hLL1-DOX
Previous Study | Return to List | Next Study

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01585688
Recruitment Status : Unknown
Verified September 2015 by Immunomedics, Inc..
Recruitment status was:  Active, not recruiting
First Posted : April 26, 2012
Last Update Posted : September 7, 2015
Information provided by (Responsible Party):
Immunomedics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : November 2016
  Estimated Study Completion Date : February 2017